Finch Therapeutics Group (FNCH)
OTHER OTC:FNCH
US Market
Holding FNCH?
Track your performance easily

Finch Therapeutics Group (FNCH) Financial Statements

61 Followers

Finch Therapeutics Group Financial Overview

Finch Therapeutics Group's market cap is currently ―. The company's EPS TTM is $-8.823; its P/E ratio is -1.34; Finch Therapeutics Group is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 1.05M--$ 959.00K$ 107.00K
Gross Profit$ 1.05M--$ 959.00K$ 107.00K
EBIT$ -4.83M$ -3.88M$ -3.73M$ -6.95M$ -32.91M
EBITDA$ -4.79M$ -3.83M$ -3.68M$ -6.89M$ -31.54M
Net Income Common Stockholders$ -4.83M$ -3.88M$ -2.42M$ -6.95M$ -29.45M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 16.04M$ 20.76M$ 28.80M$ 34.10M$ 41.70M
Total Assets$ 45.58M$ 50.09M$ 59.49M$ 66.86M$ 79.04M
Total Debt$ 28.99M$ 29.56M$ 30.77M$ 31.04M$ 36.13M
Net Debt$ 12.95M$ 8.80M$ 1.97M$ -3.06M$ -5.57M
Total Liabilities$ 31.36M$ 31.05M$ 33.68M$ 38.96M$ 46.09M
Stockholders Equity$ 14.22M$ 19.04M$ 25.81M$ 27.89M$ 32.95M
Cash Flow-
Free Cash Flow$ -4.73M$ -4.36M$ -5.26M$ -7.89M$ -13.39M
Operating Cash Flow$ -4.73M$ -4.36M$ -5.26M$ -9.16M$ -13.38M
Investing Cash Flow--$ 20.00K$ 1.27M$ -14.00K
Financing Cash Flow---$ 4.00K$ -16.16M
Currency in USD

Finch Therapeutics Group Earnings and Revenue History

Finch Therapeutics Group Debt to Assets

Finch Therapeutics Group Cash Flow

Finch Therapeutics Group Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis